Search Count: 1
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1S |